AGL — Agilon Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapValue Trap

Annual income statement for Agilon Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,521	2,388	4,316	6,061	5,933
Cost of Revenue
Gross Profit	164	294	308	218	-45.3
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,894	2,499	4,548	6,353	6,396
Operating Profit	-372	-111	-232	-292	-463
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-383	-90.7	-194	-249	-404
Provision for Income Taxes
Net Income After Taxes	-384	-92.3	-195	-250	-405
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-406	-107	-263	-260	-391
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-406	-107	-263	-260	-391
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.01	-0.213	-0.477	-0.596	-0.913